{
    "SPADE_UN_26832": {
        "Sequence Information": {
            "Peptide Name": "Ranatuerin R2AW (1-22)[D4,19K;K20L]",
            "Sequence": "GFMKTAKNVAKNVAATLLKLLK",
            "Sequence Length": 22,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell",
                "Antibiofilm"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "G3XHN9",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/G3XHN9",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Progressive Design of a Ranatuerin-2 Peptide from Amolops wuyiensis: Enhancement of Bioactivity and In Vivo Efficacy.",
                    "Pubmed ID": "38275314",
                    "Reference": "Antibiotics (Basel). 2023;13:5",
                    "Author": "Yao A, Liu T, Cai Y, Zhou S, Chen X, Zhou M, Ma C, Chen T, Shaw C, Wang L",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/38275314"
                }
            ],
            "Mass": 2359.91,
            "PI": 10.6,
            "Net Charge": 5,
            "Hydrophobicity": 0.33,
            "Frequent Amino Acids": "KAL",
            "Absent Amino Acids": "CDEHIOPQRSUWY",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 12,
            "Polar Residues": 10,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26832",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_26832",
                    "Similarity": 1.0,
                    "Sequence": "GFMKTAKNVAKNVAATLLKLLK"
                },
                {
                    "SPADE_ID": "SPADE_N_05862",
                    "Similarity": 1.0,
                    "Sequence": "KLLKHKLLVTLA"
                },
                {
                    "SPADE_ID": "SPADE_N_09624",
                    "Similarity": 1.0,
                    "Sequence": "LKLLKLL"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:40% Hemolysis=128 µM,Horse erythrocytes:78% Hemolysis=256 µM",
            "Target Organism": "Human lung adenocarcinoma NCI-H838(IC50=7.828µM),Human prostate adenocarcinoma PC-3(IC50=3.671µM),Human glioblastoma U251-MG(IC50=12.40µM),Human breast adenocarcinoma MCF-7(IC50=10.58µM),Human colon adenocarcinoma HCT 116(IC50=9.284µM),Staphylococcus aureus NCTC 10788(MIC=2µM),Staphylococcus aureus NCTC 10788(MBC=2µM),Escherichia coli ATCC 8739(MIC=2µM),Escherichia coli ATCC 8739(MBC=4µM),Staphylococcus aureus NCTC 12493(MIC=2µM),Staphylococcus aureus NCTC 12493(MBC=2µM),Klebsiella pneumoniae ATCC 43816(MIC=4µM),Klebsiella pneumoniae ATCC 43816(MBC=8µM),Enterococcus faecium NTCC 12697(MIC=4µM),Enterococcus faecium NTCC 12697(MBC=8µM),Pseudomonas aeruginosa ATCC 9027(MIC=8µM),Pseudomonas aeruginosa ATCC 9027(MBC=16µM)"
        }
    }
}